BEAM
Price
$23.70
Change
+$0.08 (+0.34%)
Updated
Nov 25, 11:35 AM (EDT)
Capitalization
2.4B
98 days until earnings call
Intraday BUY SELL Signals
FDMT
Price
$10.89
Change
+$0.05 (+0.46%)
Updated
Nov 24 closing price
Capitalization
622.2M
94 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs FDMT

Header iconBEAM vs FDMT Comparison
Open Charts BEAM vs FDMTBanner chart's image
Beam Therapeutics
Price$23.70
Change+$0.08 (+0.34%)
Volume$3.93K
Capitalization2.4B
4D Molecular Therapeutics
Price$10.89
Change+$0.05 (+0.46%)
Volume$486.49K
Capitalization622.2M
BEAM vs FDMT Comparison Chart in %
BEAM
Daily Signal:
Gain/Loss:
FDMT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BEAM vs. FDMT commentary
Nov 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and FDMT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 25, 2025
Stock price -- (BEAM: $23.64 vs. FDMT: $10.89)
Brand notoriety: BEAM and FDMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 173% vs. FDMT: 54%
Market capitalization -- BEAM: $2.4B vs. FDMT: $622.2M
BEAM [@Biotechnology] is valued at $2.4B. FDMT’s [@Biotechnology] market capitalization is $622.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.58B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileFDMT’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • FDMT’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than FDMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while FDMT’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 6 bearish.
  • FDMT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, FDMT is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +7.36% price change this week, while FDMT (@Biotechnology) price change was -0.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.12%. For the same industry, the average monthly price growth was -2.25%, and the average quarterly price growth was +67.31%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 03, 2026.

FDMT is expected to report earnings on Feb 27, 2026.

Industries' Descriptions

@Biotechnology (+2.12% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.4B) has a higher market cap than FDMT($622M). FDMT YTD gains are higher at: 95.512 vs. BEAM (-4.677). FDMT has higher annual earnings (EBITDA): -213.2M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. FDMT (293M). FDMT has less debt than BEAM: FDMT (23.1M) vs BEAM (155M). BEAM has higher revenues than FDMT: BEAM (60.3M) vs FDMT (33K).
BEAMFDMTBEAM / FDMT
Capitalization2.4B622M386%
EBITDA-414.33M-213.2M194%
Gain YTD-4.67795.512-5%
P/E RatioN/AN/A-
Revenue60.3M33K182,727%
Total Cash1.15B293M392%
Total Debt155M23.1M671%
TECHNICAL ANALYSIS
Technical Analysis
BEAMFDMT
RSI
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 16 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 1 day ago
74%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
FDMT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TIBIX31.870.21
+0.66%
Thornburg Investment Income Builder I
AEDRX36.39N/A
N/A
Invesco International Value R
MMUHX25.79N/A
N/A
MFS Utilities R3
WCMSX23.88N/A
N/A
WCM International Small Cap Growth Instl
NEXIX33.57N/A
N/A
Shelton Sustainable Equity Institutional